Physician profile
Ashish Kumar Mathur
NPI 1639499841
$453.94
in general payments reported to CMS, 2019-2025
8 companies · $16.13 in 2025
The $16.13 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.87 · 2020: $26.41 · 2021: $52.91 · 2022: $77.69 · 2023: $189 · 2024: $51.30 · 2025: $16.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $188.81 | 2019-2025 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $102.41 | 2021-2022 | |
| Blueprint Medicines Corporation | $51.30 | 2024 | Ayvakit |
| Astrazeneca Pharmaceuticals Lp | $37.13 | 2019-2023 | Airsupra |
| Aimmune Therapeutics, INC. | $28.19 | 2021 | |
| Csl Behring | $17.26 | 2019 | |
| Allergan, INC. | $14.85 | 2020 | |
| Genzyme Corporation | $13.99 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashish Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.